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BACKGROUND: Why some but not all patients with severe aortic stenosis 
(SevAS) develop otherwise unexplained reduced systolic function is unclear. 
We investigate the hypothesis that reduced creatine kinase (CK) capacity and 
flux is associated with this transition.
METHODS: We recruited 102 participants to 5 groups: moderate aortic 
stenosis (ModAS) (n=13), SevAS, left ventricular (LV) ejection fraction ≥55% 
(SevAS-preserved ejection fraction, n=37), SevAS, LV ejection fraction 
<55% (SevAS-reduced ejection fraction, n=15), healthy volunteers with 
nonhypertrophied hearts with normal systolic function (normal healthy 
volunteer, n=30), and patients with nonhypertrophied, non–pressure-loaded 
hearts with normal systolic function undergoing cardiac surgery and donating 
LV biopsy (non–pressure-loaded heart biopsy, n=7). All underwent cardiac 
magnetic resonance imaging and 31P magnetic resonance spectroscopy for 
myocardial energetics. LV biopsies (AS and non–pressure-loaded heart biopsy) 
were analyzed for CK total activity, CK isoforms, citrate synthase activity, and 
total creatine. Mitochondria-sarcomere diffusion distances were calculated by 
using serial block-face scanning electron microscopy.
RESULTS: In the absence of failure, CK flux was lower in the presence of 
AS (by 32%, P=0.04), driven primarily by reduction in phosphocreatine/ATP 
(by 17%, P<0.001), with CK kf unchanged (P=0.46). Although lowest in the 
SevAS-reduced ejection fraction group, CK flux was not different from the 
SevAS-preserved ejection fraction group (P>0.99). Accompanying the fall in 
CK flux, total CK and citrate synthase activities and the absolute activities 
of mitochondrial-type CK and CK-MM isoforms were also lower (P<0.02, all 
analyses). Median mitochondria-sarcomere diffusion distances correlated well 
with CK total activity (r=0.86, P=0.003).
CONCLUSIONS: Total CK capacity is reduced in SevAS, with median values 
lowest in those with systolic failure, consistent with reduced energy supply 
reserve. Despite this, in vivo magnetic resonance spectroscopy measures of 
resting CK flux suggest that ATP delivery is reduced earlier, at the moderate 
AS stage, where LV function remains preserved. These findings show that 
significant energetic impairment is already established in moderate AS and 
suggest that a fall in CK flux is not by itself a necessary cause of transition to 
systolic failure. However, because ATP demands increase with AS severity, this 
could increase susceptibility to systolic failure. As such, targeting CK capacity 
and flux may be a therapeutic strategy to prevent and treat systolic failure in AS.
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In patients with severe aortic stenosis (SevAS), reduc-tions in left ventricular ejection fraction (LVEF) in-crease mortality irrespective of symptoms. Although 
most patients present with preserved systolic function, 
~30% of asymptomatic patients have borderline LVEF 
(50%–59%),1–3 and 15% of those undergoing surgi-
cal aortic valve replacement have reduced LVEF (LVEF 
<50%).2 At present, identifying all individuals who 
develop an otherwise unexplained decline in LVEF in 
the face of pressure overload is not possible,4 and why 
some but not all patients with SevAS develop otherwise 
unexplained reduced LVEF is unclear.
Given the direct coupling of ATP metabolism and 
contractile function, metabolic reserve could represent 
an early and specific marker of vulnerability to failure 
in the face of pressure overload. In the heart, ATP de-
livery can occur through the creatine kinase (CK) sys-
tem, which catalyzes the following reversible reaction: 
Phosphocreatine + ADP + H+ ↔ Creatine + ATP. How-
ever, in addition to this shuttle function, the CK system 
can also act as a buffer to dampen changes in ATP and 
ADP levels. Although the relative importance of these 
2 functions is unclear, the CK system is important to 
preserve the free energy of ATP hydrolysis in the cytosol 
(Figure  1), a key determinant of contractile function, 
and it is established that CK capacity (estimated by CK 
Total Activity×[Total Creatine])5 represents an important 
metabolic reserve, in particular, at high workloads, and 
correlates closely with contractile reserve.5–7
Because both reduced CK maximum capacity and 
CK flux (the rate of total ATP transfer by CK under pre-
vailing conditions in vivo) have been associated with 
transition to failure in animal models of pressure over-
load8–14 and in human hypertensive hypertrophy15 and 
dilated cardiomyopathy,16,17 this may be an important 
determinant of transition to failure in AS, but this has 
not been explored.
In addition to CK-facilitated transfer, ATP may also 
diffuse directly between mitochondria and contractile 
sites (Figure 1). As such, the distance over which ATP 
has to diffuse may also affect CK efficacy. In support 
of this, when CK capacity is impaired in CK knockout 
models, there is evidence of ultrastructural compensa-
tion that effectively reduces this diffusion distance.18,19 
To date, however, no such measurements exist in hu-
man AS. In addition, upstream of ATP transfer, meta-
bolic reserve may be compromised at the level of mi-
tochondrial oxidative capacity, but few human studies 
assessing phosphotransfer have also measured an index 
of mitochondrial capacity.
Therefore, this study aimed to use the combination 
of cardiac magnetic resonance, echocardiography, and 
biopsy measurements to investigate whether (1) altered 
CK activity and isoform expression, (2) altered mito-
chondrial oxidative capacity (measured by citrate syn-
thase activity), or (3) ATP diffusion distance measures 
on scanning electron microscopy were associated with 
transition to failure in human SevAS.
METHODS
The data, analytic methods, and study materials will not be 
made available to other researchers for purposes of reproduc-
ing the results or replicating the procedure, because ethical 
approval to store tissue expires in April 2020 and insufficient 
tissue remains to replicate results in all patients. All work was 
approved prospectively by regional (South Central Oxford C, 
16/SC/0323) and local ethics and governance committees. All 
participants were recruited from clinical activity at the Oxford 
University Hospitals National Health Service Foundation Trust 
or by poster advertisement. All participants gave formal writ-
ten consent before all study procedures. Research was per-
formed in accordance with institutional procedures and the 
principles of the Declaration of Helsinki.
Inclusion Criteria
Participants were included if they were 18 to 85 years of age 
and were willing to take part in research. Patients with SevAS 
were scheduled for aortic valve replacement with either 
reduced (defined as LVEF <55%) or preserved (defined as LVEF 
≥55%) systolic function. Systolic function was determined by 
cardiac magnetic resonance. Patients with nonhypertrophied, 
non–pressure-loaded hearts with normal systolic function 
undergoing cardiac surgery willing to have biopsies taken 
were also recruited.
Exclusion Criteria
Participants were excluded if they had known previous 
myocardial infarction, flow-limiting coronary artery disease, 
more than mild bystander valve disease, significant renal 
Clinical Perspective
What Is New?
• Total creatine kinase (CK) activity is reduced in 
severe aortic stenosis (SevAS) with preserved sys-
tolic function and is lowest in AS with systolic 
failure.
• At rest, CK flux is not different between AS with 
preserved systolic function and AS with systolic fail-
ure, and is reduced in moderate AS.
• Reduced CK activity is associated with CK isoform 
redistribution and cytoarchitectural reorganization 
with a reduction in mitochondrial-sarcomere (ATP) 
diffusion distance.
What Are the Clinical Implications?
• In the presence of SevAS, reduced CK flux is unlikely 
to be sufficient alone to cause systolic failure, but 
may predispose to the transition to systolic failure 
in some patients.
• Targeting CK capacity and flux may be a therapeu-
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impairment, pregnancy, or any other contraindication to 
magnetic resonance imaging scanning. All patients listed for 
surgery had flow-limiting coronary atheroma excluded by 
invasive angiography and prior myocardial infarction excluded 
by late gadolinium enhancement imaging.
On the basis of these criteria, 102 participants were recruited 
to 5 groups: (1) SevAS, LVEF ≥55% (SevAS with preserved ejec-
tion fraction [SevAS-pEF], n=37); (2) SevAS, LVEF<55% (SevAS 
with reduced ejection fraction [SevAS-rEF], n=15); (3) moder-
ate AS, LVEF >55% ([ModAS], n=13); (4) patients with nonhy-
pertrophied, non–pressure-loaded hearts with normal systolic 
function undergoing surgery (non–pressure-loaded heart 
biopsy [NHBx],  n=7); and (5) volunteers with non–pressure-
loaded hearts with normal systolic function not undergoing 
cardiac surgery (normal healthy volunteer [NHv], n=30).
Myocardial Biopsies
Twenty-six patients with SevAS-pEF, 10 with SevAS-rEF, and 7 
with NHBx donated intraoperative biopsies sufficiently large 
to measure creatine and CK total activity. Indications for sur-
gery in biopsied patients with a normal heart were mitral 
stenosis (n=4), ascending aortic aneurysm (n=1), and benign 
left atrial mass (n=1). One NHBx sample was not analyzable 
because of a technical error in the fixing process, leaving 6 for 
the biopsy analysis in this group.
Cardiac Magnetic Resonance
All cardiac magnetic resonance was performed on a 3T mag-
netic resonance imaging scanner (Tim Trio; Siemens) and, 
unless stated, was analyzed using cvi42 (Circle Cardiovascular 
Imaging Inc).
Left Ventricular Imaging
A short stack of cine images was obtained and analyzed by using 
a 24-channel spine matrix, 6-channel body matrix, and steady-
state free precession sequences as previously described.20 In 
brief, all images were ECG gated and taken during end-expira-
tory breath-hold. Typical steady-state free precession sequence 
parameters were slice thickness 8 mm, gap 2 mm, retrospective 
gating, echo time 1.5 ms, repetition time (TR) 46 ms, flip-angle 
50º, field of view 400 mm, and matrix size 256 in frequency 
encode direction. Prospective gating was used when the par-
ticipant was in atrial fibrillation. Left ventricular (LV) endocar-
dial and epicardial contours were performed manually in cvi42. 
LV mass index was normalized to body surface area using the 
Mosteller formula. Late gadolinium imaging according to clini-
cal protocols was performed to exclude myocardial infarction 
(further details in Methods in the Data Supplement).
Cardiac 31P Magnetic Resonance 
Spectroscopy
All magnetic resonance spectroscopy was performed before 
cardiac magnetic resonance imaging.
Phosphocreatine/ATP
Participants were positioned prone over a 3-element dual-
tuned 1H/31P surface coil at magnet isocenter. An 11-min-
ute nongated 3-dimensional acquisition-weighted ultrashort 
echo time chemical shift imaging sequence was run as pre-
viously described.21 Parameters included acquisition matrix 
size 16×16×8 voxels, field of view 240×240×200 mm3, nomi-
nal voxel size 5.6 mL, 10 averages at the center of k-space, 
fixed TR per subject (910–1010 ms depending on specific 
absorption rate constraints), center frequency 250 Hz from 
Figure 1. A schematic of adenine nucleotide transfer pathways in the heart.
This figure shows simple diffusion of ATP, ADP, and inorganic phosphate (Pi), and CK-facilitated transport operating in the ATP-generating direction (rate constant 
kf) and PCr-generating direction (rate constant kr). In oxidative muscle under normoxic conditions, cytosolic CK isoforms (CK-MM, -MB, -BB) typically work in 
the ATP-generating direction, whereas mitochondrial CK works in the PCr-generating direction. Forward CK flux is defined by kf×[PCr], where kf is the pseudo–
first-order unidirectional rate constant in the ATP-generating direction measured using saturation transfer 31P magnetic resonance spectroscopy. This should be 
distinguished from CK total activity (VMax), which represents maximal velocity in the presence of saturating amounts of substrate and requires destructive freeze-
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phosphocreatine (PCr). The PCr/ATP ratio reported is the 
blood- and saturation-corrected PCr/average ATP ratio, aver-
aged over the 2 most basal septal voxels. Spectral analysis 
was performed using OXSA, an open-source MATLAB imple-
mentation of the Advanced Method for Accurate, Robust and 
Efficient Spectral fitting (AMARES) algorithm.22
Creatine Kinase kf
CK kf was estimated using triple TR saturation transfer 
adapted for use with a transmit/receive 10-cm loop radio-
frequency coil (PulseTeq Ltd) as previously described.23,24 In 
brief, participants were scanned supine; 1H localizers con-
firmed coil position; then a 1-dimensional phase-encoded 
chemical shift imaging matrix (16 slices, 160 mm) was used 
to acquire 4 sets of 31P spectra. These were a fully relaxed 
acquisition (TR 15 s, 2 averages, 9 minutes), 2 acquisitions 
with selective γATP saturation (TR 1.5 then 9.5 s, 18 then 
8 averages, 11 then 21 minutes), and 1 with control satu-
ration mirrored around PCr (TR 15 s, 2 averages, 9 min-
utes) (Figure  2A). Spectral analysis was performed using 
custom software as previously described.24 The pseudo–
first-order unidirectional rate constant (kf) of CK in the 
ATP-generating (forward) direction was calculated accord-




















Forward CK flux was calculated by [PCr]×kf, where [PCr] is 
estimated by multiplying PCr/ATP by literature values for [ATP] 
(5.7 or 5.2 μmol/g wet weight, the lower value applied to 
those patients with reduced LVEF).16 We multiplied all kf val-
ues by a previously validated factor of 1.333 to adjust for 
supine scanning.24
Echocardiography
Measurements of the aortic valve were made using standard 
clinical echocardiography 2-dimensional and Doppler exami-
nation of the aortic valve and LV outflow tract (Philips Epiq 
system). AS was graded on echocardiography according to 
international guidelines.25
Left Ventricular Biopsies
Surgical myocardial biopsies were obtained from LV endo-
cardium 10 to 20 minutes after starting cardiopulmonary 
bypass and immediately divided into 2 parts. One part was 
frozen in liquid nitrogen within 20 seconds of excision and 
stored at –80°C until analysis; the other was immediately 
immersed in chemical fixative and further dissected for elec-
tron microscopy.
Enzyme Activities, CK Isozyme Distribution, and 
Total Creatine Content
Frozen, powdered samples were analyzed according to estab-
lished protocols for CK total activity (averaged over 3 runs, 
normalized to Lowry protein [mg/mL], presented as IU/mg 
protein), CK isoforms (expression relative to total CK), citrate 
synthase (CS) activity (averaged over 2 runs, IU/mg protein), 
and total creatine concentration (nmol/mg protein), as pre-
viously described.26 (Further details in Methods in the Data 
Supplement.)
Mitochondria-Sarcomere ATP/ADP Diffusion 
Distance
Samples for serial block-face scanning electron microscopy 
were fixed and stained with heavy metals for enhanced 
contrast as previously described,27 then dehydrated in a 
Figure 2. Validation of noninvasive assessment of CK activity.
A, Representative spectra constituting the triple repetition time saturation transfer method for estimating CK kf in a cardiac voxel of interest. B, Absolute CK 
activity measured from left ventricular biopsy correlated with CK capacity estimated by total creatine×kf  (adjusted for supine scanning). Dante (Delays Alternating 
with Nutation for Tailored Excitation) is the pulse sequence used for selective saturation of γATP or the control position methods to assess, and in vivo CK capac-
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progressive ethanol series, infiltrated with Durcupan epoxy 
resin, and polymerized at 60°C for 72 hours. Samples were 
mounted in a Zeiss Merlin Compact Field Emission Gun-
Scanning Electron Microscope with Variable Pressure and 
a Gatan 3View System and underwent serial block-face 
sectioning (serial block-face scanning electron microscopy) 
(typical acquisition parameters: magnification 6100×, 
voltage 3 kV, dwell time 6 ms, pressure 0.3 torr, field of 
view 40 µm [4000 pixels] square, in-plane [x–y] resolution 
10 nm, slice thickness 100 nm). Samples were analyzed 
in Microscopy Image Browser version 2.0.1 for MATLAB. 
After applying Perona-Malik anisotropic diffusion filters 
and grayscale thresholding, manual segmentation was per-
formed over every other slice, to define mitochondria and 
sarcomeres in a total of 31 slices per data set. For each 
pixel-labeled sarcomere, an algorithm computed the diffu-
sion distance, defined as the minimum 3-dimensional dis-
tance to the nearest pixel-labeled mitochondrion. As such, 
the diffusion distance was recorded from the mitochondrial 
edge. Diffusion distance distributions resembled log-nor-
mal distributions and were summarized by median distance 
(see Methods in the Data Supplement).
STATISTICAL ANALYSIS
Data were reported as means (with SDs) for continu-
ous variables passing Shapiro-Wilk testing for normality 
and medians (with interquartile range) if not. Box plots 
depict medians, interquartile range, and whiskers, with 
whiskers extending to the maximum value of the data 
within 1.5 times the interquartile range over the third 
quartile, and the minimum value within 1.5 times the 
interquartile range below the first quartile.
The relationships between CK total activity and 
other invasive and noninvasive candidate predictor 
variables were explored by using linear regression 
models. In addition, invasive and noninvasive mea-
sures between the SevAS-pEF, SevAS-rEF, and NHv 
and NHBx groups were compared. Continuous vari-
ables were compared with parametric tests if the 
Shapiro-Wilk test and Levene test of between-group 
homogeneity of variance were passed. The Welch 
correction was used for unequal sample sizes or if the 
assumption of homogeneity of variance was violated. 
If normality assumptions were not met, nonparamet-
ric tests were used (Kruskal-Wallis for differences be-
tween >2 independent groups, Jonckheere-Terpstra 
for ordering of medians across >2 groups). P≤0.05 
was used as a threshold of significance. P values were 
adjusted on post hoc pairwise t tests or Wilcoxon 
rank-sum tests with the Benjamini-Hochberg method 
to control the false discovery rate. Pairwise compari-
sons were 2-sided unless otherwise stated. Categori-
cal variables were compared by χ2 or, if expected cell 
counts were <5, by the Fisher exact test. Analyses 




Participant anthropometric and clinical data are shown 
in Table 1. In the comparison of the NHv, NHBx, ModAS, 
SevAS-pEF, and SevAS-rEF groups, the proportion of 
men did not significantly differ, but the median age, 
body mass index, systolic blood pressure, 6-minute 
walk distance, history of hypertension, prevalence of 
left bundle-branch block or ECG LV strain pattern, and 
the proportion using cardiac medications did.
Aortic Valve Assessment
Transthoracic Doppler and 2-dimensional echocardiog-
raphy measurements of the aortic valve in both SevAS-
pEF (VMax 4.4±0.55 m/s, peak gradient 81±20 mm Hg, 
mean gradient 46±14 mm Hg, aortic valve area calculat-
ed by continuity equation 0.83±0.33 cm2) and SevAS-
rEF groups (VMax 4.1±0.72 m/s, peak gradient 67±26 
mm Hg, mean gradient 39±16 mm Hg, aortic valve area 
calculated by continuity equation 0.62±0.21 cm2) con-
firmed the presence of SevAS. ModAS was confirmed 
in the ModAS group (VMax 3.3±0.10 m/s, peak gradient 
44±8 mm Hg, mean gradient 24±5 mm Hg, aortic valve 
area calculated by continuity equation 1.2±0.2 cm2).
LV Characteristics
As expected, because of the recruitment criteria, LVEF 
was normal in the SevAS-pEF (66±5%), NHv and NHBx 
groups (61±4%), and ModAS group (65±6%), but sig-
nificantly lower in the SevAS-rEF group (40±9%, P<0.001; 
Figure 3A). In comparison with the non–pressure-loaded 
heart groups, mean indexed LV end-diastolic volume (mL/
m2) was lower in the SevAS-pEF group (by 12%, P=0.03) 
and larger in the SevAS-rEF groups (by 36%, P<0.001; Fig-
ure 3B). Mean LV mass indexed to body surface area (g/
m2) was also increased in all SevAS groups in comparison 
with the non–pressure-loaded groups (Figure 3C). LV mass 
correlated with New York Heart Association class for those 
undergoing surgery (LV mass index, r=0.29, P=0.04).
CK Flux Validation
To validate the triple TR saturation transfer measure-
ment of CK activity, noninvasive estimates were corre-
lated against ex vivo total CK activity from 32 patients 
who had undergone both 31P triple TR saturation trans-
fer measurements and intraoperative LV biopsy. When 
ex vivo CK activity was correlated with triple TR satura-
tion transfer measured in vivo CK kf (r=0.45, P=0.01), 
CK flux (r=0.37, P=0.04), and CK kf [total creatinebiopsy] 
(r=0.65, P=5×10–5; Figure 2B), there was good correla-
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Myocardial Energetics in the Pressure-
Loaded LV
To assess whether pressure loading was associated with 
altered myocardial energetics, all data from participants 
with AS and normal systolic function (ModAS and Se-
vAS-pEF) were compared with all non–pressure-loaded 
hearts (NHv and NHBx groups). This showed that pres-
sure loading (peak 71±23 mm Hg) was associated with 
a 17% lower PCr/ATP (P<0.001), no difference in CK kf 
(P=0.46), and a 32% lower CK flux (P=0.04). Reduced 
CK flux was driven predominantly by reduced PCr pool 
size (by 17%, P<0.001).
Myocardial Energetics and the Transition to 
Failure
To assess whether the altered energetics were associ-
ated with transition to failure, ModAS, SevAS-pEF, and 
SevAS-rEF were compared with the non–pressure-load-
ed groups.
Myocardial PCr/ATP ratios in all AS groups, including 
SevAS-rEF, were lower than that recorded in the nonhy-
pertrophied heart (by 16%–21%; Figure 3D). Although 
PCr/ATP was lower in SevAS-rEF than in the non–pres-
sure-loaded heart, it was not different from SevAS-pEF 
(P>0.99). PCr/ATP was also reduced in ModAS (by 21%, 
Table 1. Participants’ Demographics and Medical and Drug History
Demographics NHv (n=30) NHBx (n=7) ModAS (n=13) SevAS-pEF (n=28) SevAS-rEF (n=13) P Value
Anthropometric data
  Age, y 38 (29–54) 73 (65–75) 79 (69–80) 72 (69–78) 75 (65–81) <0.001
  Body mass index, kg/m2 25 (23–28) 22 (21–29) 27 (24–32) 28 (25–30) 29 (26–31) 0.002
  Male, n (%) 16 (53) 1 (14) 7 (54) 16 (57) 8 (62) 0.55*
  Systolic blood pressure, mm Hg 124 (17) 117 (23) 142 (25) 145 (19) 129 (12) 0.004
  Diastolic blood pressure, mm Hg 69 (12) 67 (12) 71 (16) 73 (10) 74 (8) 0.05
  Mean arterial pressure, mm Hg 88 (11) 84 (14) 95 (18) 97 (11) 92 (7) 0.008
  Heart rate, bpm 60 (53–65) 70 (69–90) 64 (53–89) 65 (58–71) 67 (62–71) 0.04
Symptomatic and functional status, n (%)
  1 N/A 2 (29) N/A 9 (32) 2 (15)  
  2 N/A 3 (43) N/A 12 (43) 6 (46)  
  3 N/A 2 (29) N/A 7 (25) 5 (38)  
  6-min walk distance, m 606 (63) 400 (391, 490) 455 (145) 429 (118) 321 (152) <0.001
Medical history, n (%)
  Diabetes mellitus 0 (0) 2 (29) 1 (8) 3 (11) 1 (8) 0.05*
  Hypertension 1 (3) 2 (29) 6 (46) 17 (61) 5 (38) <0.001*
  Venous thromboembolism 1 (3) 0 (0) 0 (0) 2 (7) 1 (8) 0.81*
  Transient ischemic attack/stroke 0 (0) 1 (14) 2 (15) 4 (14) 1 (8) 0.11*
  Current smoker 0 (0) 0 (0) 1 (8) 3 (11) 0 (0) 0.30*
  Prior smoker 10 (33) 2 (29) 2 (15) 14 (50) 3 (23) 0.23*
  Atrial fibrillation 1 (3) 3 (43) 3 (23) 4 (14) 2 (15) 0.03*
  Left bundle-branch block 1 (3) 0 (0) 0 (0) 1 (4) 4 (31) 0.03*
  T-wave inversion or left ventricular strain 0 (0) 0 (0) 2 (17) 10 (36) 8 (62) <0.001*
Drug history, n (%)
  β-Blocker 1 (3) 4 (57) 5 (38) 9 (32) 6 (46) 0.01*
  Angiotensin-converting enzyme 
inhibitor/angiotensin receptor blocker
2 (7) 2 (33) 7 (46) 13 (46) 7 (54) 0.001*
  Mineralocorticoid receptor antagonist 0 (0) 0 (0) 0 (0) 0 (0) 5 (38) <0.001*
  Loop diuretic 0 (0) 1 (14) 1 (8) 7 (25) 4 (31) 0.01*
  Antiplatelet 0 (0) 0 (0) 4 (31) 13 (46) 3 (23) <0.001*
  Oral anticoagulant  1 (3) 4 (57) 2 (15) 4 (14) 2 (15) 0.01*
Values shown are n (%). Continuous variables shown are mean (SD) or median (interquartile range). The numbers analyzed in each group (n) varied from the 
recruited sample size, given that some patients aborted scans because of claustrophobia; therefore, only data sets where creatine kinase flux was performed are 
shown. ModAS indicates moderate aortic stenosis; NH, normal heart; NHBx, non–pressure-loaded heart biopsy; NHv, normal healthy volunteer; SevAS-pEF, severe 
aortic stenosis with preserved ejection fraction; and SevAS-rEF, severe aortic stenosis with reduced ejection fraction.
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P<0.01; Figure 3D). CK kf was not statistically different 
between groups (P=0.76; Figure 3E).
CK flux was lowest in the failing AS heart (by 
27% in comparison with the combined NHv+Bx 
group), and, when groups were ordered NHBx + 
NHv > ModAS > SevAS-pEF > SevAS-rEF, this showed 
that median CK flux decreased as LV mass increased 
(P=0.047; Figure 3F).
Overall this shows that AS is associated with reduced 
CK flux, with the reduction predominantly driven by 
a reduced PCr pool size, which is seen at the ModAS 
stage. It also shows that, although CK flux was lowest 
in SevAS with systolic failure, energetic depletion ap-
pears to precede systolic failure in AS.
CK Total Activity
In comparison with NHBx hearts, median total CK 
activity was significantly lower both in SevAS-rEF (by 
43%, post hoc one-sided P=0.016) and SevAS-pEF 
(by 35%, post hoc one-sided P=0.028), resulting in 
a decreasing trend in median values (P=0.002; Fig-
ure  4A, Table  2). Median values were also lower in 
SevAS-rEF hearts than in SevAS-pEF hearts (post hoc 
one-sided P=0.047).
Forty-two participants (26 SevAS-pEF, 10 SevAS-rEF, 
and 6 NHBx) contributed data sets eligible for corre-
lation analysis (ie, had measured CK total activity and 
total creatine), and 32 (19 SevAS-pEF, 8 SevAS-rEF, and 
5 NHBx) contributed data sets eligible for linear regres-
sion (ie, had measured CK total activity, total creatine, 
CK kf, and LV mass and volumes). CK total activity cor-
related strongly with citrate synthase activity (r=0.83, 
P=1×10–11) and well with total adenine nucleotide pool 
(r=0.50, P=2×10–5) (Figure I in the Data Supplement, 
Table I in the Data Supplement). There were good cor-
relations with total creatine concentration (r=0.57, 
P=9×10–5) and noninvasively estimated CK capacity 
(r=0.65, P=5×10–5), and moderate correlations with kf 
(r=0.45, P=0.01) and CK flux (r=0.38, P=0.04) (Figure 
Figure 3. Cardiac magnetic resonance parameters for the study groups.
LV ejection fraction (A). LV end-diastolic volume index (B), LV mass index (C), magnetic resonance spectroscopy–derived PCr/ATP ratio (D), CK kf (E), and forward 
CK flux (F) in nonhypertrophied, non–pressure-loaded healthy volunteer hearts (NHv),in non–pressure-loaded hearts with normal LVEF undergoing LV biopsy 
(NHBx), and in hearts with moderate AS (Mod-AS), SevAS with preserved (SevASpEF) and reduced (SevASrEF) ejection fraction. For between-group comparison, 
*P<0.05, **P<0.01, ***P<0.001; otherwise P>0.05. AS indicates aortic stenosis; CK, creatine kinase; LVEDVi, indexed left ventricular end-diastolic volume; LVEF, 
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II in the Data Supplement). There was a moderate posi-
tive correlation with LVEF (r=0.40, P=0.01) and moder-
ate negative correlations with indexed LV end-diastolic 
volume (r=–0.51, P=0.001), indexed LV end-systolic 
volume (r=–0.50, P=0.001), LV mass index (r=–0.44, 
P=0.004), and magnetic resonance imaging–derived 
global circumferential strain (r=–0.52, P=0.001) (Figure 
III in the Data Supplement). Correlations with nonin-
dexed LV volumes and mass were weaker than with 
indexed counterparts, and not presented. There was 
no correlation with PCr/ATP ratio. There were only 2 
significant correlates of CK kf: CK total activity (r=0.45, 
P=0.01) and CK/CS activity ratio (r=0.48, P=0.005).
CS Activity, Total Creatine, and CK Capacity
There was also a significant decreasing trend in median 
CS activity, an additional marker of oxidative capacity 
(NHBx > SevAS-pEF > SevAS-rEF, P=0.001; Figure 4B), 
with median CS activity being 30% lower in the Se-
vAS-rEF than NHBx hearts (P<0.01), and 14% lower in 
SevAS-pEF than in NHBx hearts (P=0.03). Median val-
ues in SevAS-rEF were 19% lower than in SevAS-pEF 
(P=0.02). Comparing total creatine (Figure  4C), there 
were no significant between-group differences (1-way 
ANOVA, P=0.6) and no decreasing trend in median val-
ues (P=0.2). A decreasing trend in estimated in vivo CK 
capacity (CK total activity×total creatine) was also seen 
Figure 4. LV biopsy obtained creatine concentration and CK and CS activities.
CK total activity (A), CS activity (B), total creatine concentration (C), estimated CK capacity (D) from nonhypertrophied, non–pressure-loaded hearts (NH), severe 
aortic stenosis with preserved (SevAS-pEF) and reduced ejection fraction (SevAS-rEF) undergoing valve replacement surgery. *Post hoc pairwise tests significant 




 http://ahajournals.org by on June 29, 2020
Peterzan et al Cardiac Energetics in Severe Human Aortic Stenosis
Circulation. 2020;141:1971–1985. DOI: 10.1161/CIRCULATIONAHA.119.043450 June 16, 2020 1979
ORIGINAL RESEARCH 
ARTICLE
(NHBx > SevAS-pEF > SevAS-rEF, P=0.016; Figure 4D), 
but post hoc pairwise tests were not significant.
Overall, this shows that in SevAS with reduced sys-
tolic function, both CK activity and CS activity (a marker 
of cellular oxidative capacity and mitochondrial density) 
were significantly reduced.
CK Isoforms
Underlying the observed falls in CK total activity, there 
were reducing trends in median absolute activities of 
mitochondrial type CK (MtCK), CK-MM, and CK-MB 
isoforms when groups were ordered by increasing LV 
mass index (NHBx > SevAS-pEF > SevAS-rEF, all P<0.01; 
Table 2, Figure 5A through 5D), with post hoc tests sig-
nificant at each step for MtCK and CK-MM. Absolute 
activities of CK-MB were also reduced in both SevAS 
groups, but activities of CK-MB and CK-BB did not dif-
fer between the SevAS groups. There were no differ-
ences in the relative expression of any isoforms with the 
exception of CK-BB, whose expression was increased in 
SevAS-rEF in comparison with NHBx (P=0.02) (Figure 5E 
Table 2. Baseline Energetic Measures and CK Isoform Expression
Parameters NHv NHBx ModAS SevAS-pEF SevAS-rEF
P Value for 
Trend in 
Medians
31P magnetic resonance 
spectroscopy, n
30 7 13 28 13  
  PCr/ATP 2.03 (0.38)†‡‖ 1.93 (0.44) 1.57 (0.36) 1.68 (0.26) 1.71 (0.38) 0.004
  Derived [PCr], μmol/g 11.5 (2.2)†‡‖ 11.0 (2.5) 9.0 (2.0) 9.6 (1.5) 8.9 (2.0) 0.003
  CK kf, S
–1 0.25 (0.21–0.35) 0.32 (0.14–0.47) 0.24 (0.14–0.36) 0.23 (0.13–0.36) 0.20 (0.16–0.30) 0.29
  CK flux, μmol·g–1·s–1 3.0 (2.3–4.0) 3.1 (1.6–5.7) 1.7 (1.0–4.4) 2.1 (1.3–2.5) 2.2 (1.8–3.3) 0.047
Transthoracic echocardiogram
  Peak gradient, mm Hg   44 (8)†‡ 82 (20) 67 (26) <0.001*
  VMax, m/s   3.3 (0.3)†‡ 4.4 (0.6) 4.1 (0.7) <0.001*
  Dimensionless valve index   0.33 (0.10)†‡ 0.24 (0.07) 0.18 (0.05) <0.001*
  Aortic valve area, cm2   1.2 (0.2)†‡ 0.83 (0.33) 0.62 (0.21) <0.001*
Invasive biopsy assessment, n  6  26 10  
  CK total activity, IU/mg 
protein
 5.47 (4.70–5.89)  3.54 (2.86–4.30)§ 3.11 (1.14–3.75)†§ 0.002





  CK activity×total creatine, 
IU.nmol/mg2
 353 (224–381)  224 (171–321) 155 (39–273) 0.016
  Total creatine, nmol/mg 
protein
 66.2 (14.5)  64.5 (25.1) 55.9 (25.6) 0.20
CK isoform expression, n  6  26 9  
  MtCK, IU/mg protein  0.83 (0.71–1.08)  0.62 (0.48–0.81)§ 0.49 (0.15–0.61)†§ 0.003
  CK-MM, IU/mg protein  2.87 (2.67–3.06)  2.17 (1.79–2.54)§ 1.56 (0.74–2.21)†§ 0.001
  CK-MB, IU/mg protein  1.47 (1.24–1.58)  0.66 (0.48–0.81)§ 0.61 (0.23–0.76)§ 0.006
  CK-BB, IU/mg protein  0.14 (0.09–0.22)  0.14 (0.08–0.26) 0.12 (0.06–0.13) 0.48
  MtCK:CK, % total CK  16.4 (15.1–17.7)  16.8 (15.5–18.6) 15.3 (13.2–17.9) 0.31
  CK-MM:CK, % total CK  54.1 (52.0–56.7)  59.8 (54.9–62.9) 58.9 (54.6–60.7) 0.53
  CK-MB:CK, % total CK  25.8 (23.6–28.4)  18.7 (15.3–21.6) 20.0 (18.0–22.7) 0.47
  CK-BB:CK, % total CK  3.0 (2.0–3.9)  4.1 (1.8–6.3) 4.5 (3.8–5.5)§ 0.09
  MtCK:CS, IU/IU  2.54 (0.49)  2.60 (0.68) 2.13 (0.77) 0.22
Continuous variables shown are mean (SD) or median (interquartile range). CK indicates creatine kinase; CK-MM, CK-MB, and CK-BB, creatine kinase MM, 
MB, and BB isoforms; CS, citrate synthase; ModAS, moderate aortic stenosis; MtCK, mitochondrial type creatine kinase isoform; NHBx, non–pressure-loaded heart 
biopsy with normal systolic function; NHv, normal healthy volunteer; PCr, phosphocreatine; SevAS-pEF, severe aortic stenosis with preserved ejection fraction; and 
SevAS-rEF, severe aortic stenosis with reduced ejection fraction.
* Parameters that differ significantly across groups. The P value presented is for trend in medians (Jonckheere-Terpstra, order NH(v+Bx) > ModAS > SevAS-pEF > 
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through 5H). Between-group differences in MtCK/CS 
activity ratio were not statistically significant.
ATP/ADP Diffusion Distance
Nine patients undergoing surgery had sufficient myo-
cardial biopsy size to undergo CK total activity analy-
sis and serial block-face scanning electron microscopy 
analysis for mitochondrial-sarcomere distances. 
When median mitochondria-sarcomere diffusion dis-
tances were plotted against CK total activity, a strong 
positive correlation was observed (Figure 6, Pearson 
r=0.86, P=0.003) where lower CK activity correlated 
with shorter ATP diffusion distance. This suggests a 
compensatory reduction in diffusion distance with 
lower CK activity.
Figure 5.  CK isoform activities in the study groups.
CK isoform activity (IU/mg protein) (A through D) and CK isoform activity relative to total CK activity (from left to right: MtCK, CK-MM, CK-MB, and CK-BB) in 1 
control and 2 AS groups (E through H). *Post hoc pairwise tests significant versus NH. †Post hoc pairwise tests significant versus SevAS-pEF. AS indicates aortic ste-
nosis; CK, creatine kinase; CK-MM, CK-MB, and CK-BB, creatine kinase MM, MB, and BB isoforms; MtCK, mitochondrial type creatine kinase isoform; NHBx, non–
pressure-loaded heart biopsy; SevASpEF, severe aortic stenosis with preserved ejection fraction; and SevAS-rEF, severe aortic stenosis with reduced ejection fraction.
Figure 6. Relationship between CK activity and ATP diffusion distance.
A and B, Single unsegmented and segmented scanning electron microscopy slice of a human cardiomyocyte from a patient with severe aortic stenosis with 
reduced systolic function. Intermediate dark clusters (segmented yellow) represent mitochondria. Magnification 6000×, voltage 3 kV, dwell time 3 ms, pressure 
0.188 Torr, image size 4000×4000 pixel (37.6×37.6 µm), slice thickness 100 nm. C, Scatterplot of CK total activity against median diffusion distance calculated by 
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The transition to systolic failure in AS increases mortal-
ity and operative risk. Given the coupling of ATP usage 
and LV contraction, we investigated the hypothesis that 
reduced CK capacity/flux is associated with otherwise 
unexplained systolic failure in human SevAS.
We show here that, in the presence of SevAS, bi-
opsy-measured total CK activity is reduced and that 
median values are lowest in those with systolic fail-
ure. We also show that there is relative CK isoform 
redistribution toward CK-MM and CK-BB. In addi-
tion, we show for the first time in human pressure 
overload that cytoarchitectural reorganization occurs 
when CK activity is lower, resulting in a reduction 
in mitochondrial to sarcomere diffusion distance. 
Furthermore, we show that despite a fall in CK to-
tal capacity, in vivo magnetic resonance spectroscopy 
measures of resting CK flux, although again reduced 
in AS, could not discriminate those with systolic fail-
ure, and changes were seen in ModAS. This suggests 
that significant energetic impairment is already es-
tablished in ModAS and that reduced CK flux is not 
by itself necessarily associated with systolic failure, 
but may predispose to failure in some patients (Cen-
tral Illustration, Figure 7).
CK Total Activity
CK total activity represents CK’s maximum ATP transfer 
capacity and buffering capacity; is an important meta-
bolic reserve, in particular, if cardiac work is increased; 
and correlates closely with contractile reserve.5–7 This 
suggests that it would be more closely correlated with 
exercise performance than with resting function in the 
Figure 7. Central illustration: the effect of pressure loading on myocardial energetics.
In comparison with the normal heart (A) energetic impairment occurs in the presence of pressure loading from aortic stenosis (AS) and is established by moderate 
AS (B). Although creatine kinase (CK) capacity reduces (green line) as AS severity increases (blue line) to severe (C) and is lowest in systolic failure (D), ATP delivery 
(CK flux, red line) at rest does not alone fall lower than that seen in moderate AS. As ATP demand increases with increasing AS severity and left ventyricular hyper-
trophy (black dotted line), this exceeds prevailing ATP delivery. In summary, energetic impairment in the CK system is present early in AS, and although it does not 
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normal heart. However, if CK total activity falls below 
the threshold needed to sustain prevailing ATP delivery 
requirements, systolic dysfunction is expected to occur. 
Although 2 studies have shown reduced CK total activ-
ity in pressure-overloaded human LV,28,29 no distinction 
was previously made between hearts with or without 
systolic dysfunction. In this study, maximal CK activity 
from LV biopsy was lowest in SevAS-rEF hearts, in line 
with noninvasive measures and with previous animal 
pressure-overload studies.10,11,14
CK Flux
Reduced CK flux has been shown to limit contractile 
reserve and contribute to the transition to systolic fail-
ure in animal studies, but it was unknown whether this 
is the case in humans. In this study, we have shown 
that the presence of significant AS was associated with 
reduced CK flux. Because CK kf itself was not reduced, 
this appears to be driven primarily by a reduction in 
PCr pool and was observed in ModAS. As a result, it 
seems likely that energetic dysfunction precedes LV 
systolic dysfunction in pressure loading. In addition, 
because there was no statistical difference in resting 
CK flux between SevAS groups with and without sys-
tolic failure, this suggests that reduced resting CK flux 
is not necessary for transition to failure. However, it 
should be noted that even this normal resting ATP de-
livery rate may still be inappropriately low, because the 
ATP demand of the heart increases with increasing AS 
severity, and the failing pressure-loaded heart becomes 
more dilated and subject to greater wall stress per 
gram myocardium. Either this increased ATP turnover 
must be accounted for by CK-independent means, or, 
if not, hearts would become more susceptible to tran-
sition to failure (Figure 7).
This result is in contrast with the previous report 
in human hypertensive heart disease,15 where PCr/ATP 
was reduced in hypertensive hypertrophy irrespective 
of heart failure status, whereas CK kf was reduced 
only in the failing group. Given the variability in CK 
total activity and CK kf observed here, it is likely that, 
in AS, CK flux is compromised primarily by a combina-
tion of PCr pool depletion and total enzyme activity 
rather than a fall in CK forward rate constant. Falls in 
PCr but not CK kf were previously observed in human 
failing myocardium after myocardial infarction30 and 
in thoracic aortic constriction models in swine at the 
nonfailing hypertrophy stage.11,31
Overall, these data show that falls in CK flux may 
appear early in the process of pressure loading and cer-
tainly before transition to failure in SevAS. Although 
these may increase susceptibility to developing systolic 
failure, a second (and in this study unrecorded) insult is 
most likely also required.
CK Isoforms
LV failure has generally been associated with a de-
crease of myocardial total CK activity and a fetal shift 
in CK isoform expression secondary to increases in the 
cytosolic brain type (CK-B) isoforms and decreases of 
the cytosolic muscle type (CK-M) and mitochondrial 
(MtCK) isoforms. Congruent with this expectation, we 
observed stepwise falls in absolute activities of MtCK 
and CK-MM, a fall in CK-MB absolute activity, and a 
50% increase in relative CK-BB expression. The mech-
anism underlying this isoform shift is unknown. We 
note that it is not seen in physiological hypertrophy; 
it is not potentiated by non–B-isoform knockout32; it is 
more marked subendocardially33; it is found in multiple 
heart failure models; and it reverses on unloading.34 
Therefore, it may relate to chronic wall stress and the 
fetal isoform shift seen across many genes in patho-
logical hypertrophy.
Most animal models of pressure overload before 
or during transition to failure found falls in MtCK and 
CK-M and rises in CK-B (ie, rises in CK-MB and CK-BB) 
in rats8,33 and dogs,12 although there are exceptions: 
in the baboon,8 nonfailing thoracic aortic constriction 
mouse,13 and thoracic aortic constriction rat.35 In line 
with the former group of studies, we observed a relative 
redistribution toward CK-MM and CK-BB. This could be 
construed as a compensatory adaptation, because CK-
MM can functionally couple to various cytosolic ATPas-
es. In addition, CK-BB has greater affinity for PCr and 
ADP (Km of CK-BB for PCr and ADP is 20%–30% and 
50%–70%, respectively, that of CK-MM36). Thus, for 
CK-B containing dimers, in comparison with CK-M, the 
ATP-producing direction is kinetically favored especially 
at low PCr levels.
CS Activity
This study also shows a stepwise fall in CS activity when 
ordered by group (NHBx > SevAS-pEF > SevAS-rEF). Al-
though only 1 marker of oxidative capacity, this suggests 
that mitochondrial oxidative capacity is reduced in the 
failing AS heart. In contrast, CS activity was unaltered in 
animal models of nonfailing pressure overload.13,34 The 
30% fall in median CS activity in the SevAS-rEF group 
has no strictly comparable human studies, but in human 
nonischemic cardiomyopathy both reduced37–39 and un-
changed activity/expression40 have been observed, as 
has an increase in CS expression after LV assist device 
implantation.41 This suggests that reduced oxidative ca-
pacity is also an important consideration in the transi-
tion to failure in SevAS. The strong correlation between 
CK and CS activities observed here would support the 
argument that the role of CK in myocardium is also pri-
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This study has shown that architectural reorganization 
occurs in human heart in the setting of reduced CK 
flux. Although it has been argued that these changes 
are physiologically unimportant given that the median 
diffusion distance values measured (0.26–0.29 µm) 
are 1 to 2 orders of magnitude smaller than noninva-
sive estimates of PCr diffusion path length in skeletal 
muscle,42 it has been shown in CK knockout models18 
that diffusion distances also shorten. In the CK knock-
out model, this shortening is hypothesized to facilitate 
CK-independent metabolite channeling, which can be 
extended to human AS given the findings in this study. 
In addition, the retarding effect of membrane barri-
ers could magnify the effect of small changes in diffu-
sion distance making these small changes in distances 
meaningful. Although this study cannot establish the 
physiological importance of this architectural reorgani-
zation, it highlights that it occurs in both rodent CK 
knockouts and human cardiac pressure loading. Thus, 
changes in CK activity do not appear to occur in isola-
tion, and architectural remodeling may occur to facili-
tate ATP metabolism.
Limitations
These results do not establish the timing of any falls 
in CK and CS activity in relation to AS severity or in-
deed LVEF trajectory, and so it is not possible to in-
fer causal relationships. To answer this would require 
within-person repeated sampling, which is infeasible 
given the requirement for LV biopsy. Nor can we es-
tablish the effect of baseline CK activity on LVEF trajec-
tory, which would require longitudinal design. We did 
not assess the CK system under conditions of acutely 
increased stress, when the CK system is thought to be 
most important, because contractile reserve and stress 
testing are contraindicated in symptomatic SevAS. We 
also did not measure CK-independent phosphotransfer 
through adenylate kinase. Adenylate kinase contributes 
≈10% of phosphotransfer in the normal heart and can 
increase its contribution in heart failure (up to 21% in 
dogs), albeit not sufficiently to fully compensate for 
large changes in the CK system.43 Our estimate of CK 
flux was based on literature values of [ATP] because ab-
solute quantification was not completed.
Mitral stenosis does not represent the truly normal 
heart, but was considered the best compromise source 
of ethically accessible, nonischemic, non–pressure-
loaded, similarly aged comparator human LV.
CS activity was measured as a marker of oxidative 
capacity. Although CS activity is only a surrogate mark-
er of oxidative capacity,44,45 we feel that it was the only 
reliable way of getting a readout of oxidative capacity 
given the small (20–30 mg) LV biopsy sample size.
We did not measure classical markers of pathologi-
cal hypertrophy (atrial natriuretic peptide, α-actin, myo-
sin heavy chain) or myocardial fibrosis, because scan 
time and biopsy sizes were already at the upper limit 
of acceptable tolerance. Biopsy size also precluded a 
polarographic assessment of oxidative capacity. It is also 
possible that there were patients transitioning to failure 
in the (mostly symptomatic) SevAS-pEF group, which 
could downwardly bias CK activity values. Conversely, 
the sickest patients with SevAS-rEF could neither be re-
cruited nor biopsied, because they either felt too unwell 
to consent or were not listed for surgical aortic valve 
replacement. This could exert upward bias on values 
recorded.
CONCLUSION
Why some but not all patients with SevAS develop oth-
erwise unexplained reduced systolic function is unclear. 
This study shows that total CK capacity is reduced in 
the presence of SevAS and is lowest in those with sys-
tolic failure. Despite this, in vivo measures of resting CK 
flux, although lower in AS, could not discriminate those 
with systolic failure. In addition, we show that energetic 
impairment is established in the earlier clinical stage of 
ModAS. This suggests that significant energetic impair-
ment develops early in AS and is not a necessary corre-
late of systolic failure, but it could make patients more 
susceptible to systolic decline because ATP demands in-
crease with progressive increases in AS severity. Overall, 
these results provide a better understanding of the en-
ergetic mechanisms that underlie the transition to fail-
ure in AS and should stimulate the development of new 
therapeutic strategies in this area, for example, improv-
ing cardiac metabolism to delay transition to failure. 
Whether noninvasive metabolic imaging techniques 
could be used to identify those at risk of transition to 
failure is worthy of further investigation.
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